Direkt zum Inhalt
Merck

Anti-mycobacterial activity of a bis-sulfonamide.

Bioorganic & medicinal chemistry letters (2007-01-30)
Brendan L Wilkinson, Laurent F Bornaghi, Anthony D Wright, Todd A Houston, Sally-Ann Poulsen
ZUSAMMENFASSUNG

A bis-arylsulfonamide, 7, has been identified that exhibits growth inhibition of Mycobacterium smegmatis at less than 25 microg/mL, but has no such activity against Escherichia coli or Staphylococcus aureus. A closely related bis-arylsulfonamide (8) was much less active, but was the only other compound among 54 arylsulfonamides tested with detectable growth inhibition of M. smegmatis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Sulfanilamid, ≥98%
Sigma-Aldrich
4-Sulfamoylbenzoesäure, 97%
Sigma-Aldrich
Sulfanilamid, puriss. p.a., ≥98% (calc. to the dried substance)
Supelco
Sulfanilamid, VETRANAL®, analytical standard